301097.SHE Ningbo Tianyi Medical Appliance Co. Ltd.
- Market cap
- CNY 2.80B
- P/E
- 149.3x
- P/B
- 2.69x
- ROE
- 5.7%
- Dividend yield
- 1.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301097.SHE undervalued?
Graham numberThe Graham number of Ningbo Tianyi Medical Appliance Co. Ltd. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ningbo Tianyi Medical Appliance Co. Ltd. fundamental analysis
No fundamental analysis for Ningbo Tianyi Medical Appliance Co. Ltd. yet.
Ningbo Tianyi Medical Appliance Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ningbo Tianyi Medical Appliance Co. Ltd.
Ningbo Tianyi Medical Appliance Co., Ltd. engages in the research and development, production, and sale of medical polymer consumables and other medical devices for blood purification and ward nursing fields in China, Hong Kong, Macao, Taiwan, and internationally. The company offers hemodialysis products, including blood tubing system, artis tubing set, hemofiltration tubing, AVF, hemodialysis concentrates, bicarbonate powder, hemodialysis powder, citric acid disinfectant; a…
Full company profileNingbo Tianyi Medical Appliance Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ningbo Tianyi Medical Appliance Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 316M | 379M | 415M | 399M | 381M | 419M | 576M | 708M |
| Gross Profit | 125M | 163M | 158M | 139M | 143M | 150M | 247M | 334M |
| Operating Income | 75.7M | 116M | 103M | 67.9M | 33.4M | -19.4M | 48.3M | 85.9M |
| EBITDA | 105M | 140M | 128M | 135M | 117M | 49.7M | 59.4M | 59.4M |
| Net Income | 63.2M | 87.1M | 78.3M | 85.6M | 63.6M | -744K | -16.2M | 59.3M |
| EPS | 1.43 | 1.97 | 1.77 | 1.04 | 0.77 | -0.01 | -0.20 | 0.73 |
| Balance Sheet | ||||||||
| Total Assets | 486M | 673M | 807M | 1.63B | 1.77B | 1.79B | 2.07B | 2.32B |
| Total Liabilities | 182M | 282M | 338M | 392M | 487M | 602M | 920M | 1.28B |
| Shareholders' Equity | 304M | 391M | 469M | 1.23B | 1.27B | 1.19B | 1.15B | 1.04B |
| Cash & Short-term Investments | 107M | 186M | 346M | 449M | 192M | 407M | 437M | 544M |
| Cash Flow | ||||||||
| Operating Cash Flow | 65.5M | 121M | 133M | 50.2M | 72.6M | 58.9M | 95.1M | - |
| Capital Expenditure | 58.3M | 68.1M | 66.3M | 149M | 221M | 107M | 306M | 327M |
| Free Cash Flow | 7.13M | 53.3M | 66.7M | -98.9M | -149M | -48.1M | -210M | -384M |
| Ratios | ||||||||
| ROE | 20.8% | 22.3% | 16.7% | 6.9% | 5.0% | -0.1% | -1.4% | 5.7% |
| ROA | 13.0% | 13.0% | 9.7% | 5.3% | 3.6% | 0.0% | -0.8% | 2.6% |
| Net Profit Margin | 20.0% | 23.0% | 18.9% | 21.4% | 16.7% | -0.2% | -2.8% | 8.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ningbo Tianyi Medical Appliance Co. Ltd. dividends
- Dividend yield
- 1.48%
- Forward dividend
- 0.50 CNY
- Payout ratio
- -
- Ex-dividend date
- Jun 8, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 41.6M | 0.50 | - |
| 2024 | CNY 38.8M | 0.66 | - |
| 2023 | CNY 39.1M | 0.47 | 61.5% |
| 2022 | CNY 21.8M | 0.26 | 25.5% |
| 2021 | CNY 6.92M | 0.16 | 8.8% |
| 2020 | CNY 3.89M | 0.09 | 4.5% |
| 2019 | CNY 64.9M | 1.47 | 102.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.400354:1 on Jun 8, 2026.
Who owns Ningbo Tianyi Medical Appliance Co. Ltd.
- Insiders 72.03%
- Institutions 3.70%
- Public & others 24.27%
- Shares outstanding 81.6M
- Free float 9.14M
Ningbo Tianyi Medical Appliance Co. Ltd. company profile
- Company name
- Ningbo Tianyi Medical Appliance Co. Ltd.
- Ticker
- 301097.SHE
- ISIN
- CNE100005873
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,511
- Fiscal year end
- December
- Address
- No. 788 Mozhi North Road, Ningbo, China, 315121
- Phone
- 86 574 5501 1010
- Website
- tianyi-med.com
About Ningbo Tianyi Medical Appliance Co. Ltd.
Ningbo Tianyi Medical Appliance Co., Ltd. engages in the research and development, production, and sale of medical polymer consumables and other medical devices for blood purification and ward nursing fields in China, Hong Kong, Macao, Taiwan, and internationally. The company offers hemodialysis products, including blood tubing system, artis tubing set, hemofiltration tubing, AVF, hemodialysis concentrates, bicarbonate powder, hemodialysis powder, citric acid disinfectant; and CRRT consumables, such as customized tubing, low body weight hemofilters, plasma adsorber, MPS plasma separator, and effluent bag. It also provides single-use oxygen delivery tube, single-use oxygen nasal cannula, single-use oxygen tubing, single-use blood transfusion set, single-use burette-type infusion set with needle, and micro-adjustable infusion set. In addition, the company provides various services comprising technical identification, sterilization, clean workshop, contract technical development, and product research and development, and upgrading services; project management, cost-reduction solution, supply chain management, clinical consultancy and tracking, and sample production and testing services; and product registration support, prototype, and patent service, as well as invention program. The company was incorporated in 1998 and is headquartered in Ningbo, China.
Ningbo Tianyi Medical Appliance Co. Ltd. management
7- Mr. Zhimin WuChairman of the Board & GM · born 1963
- Mr. Kejie ShaoDeputy GM, Financial Director & Accounting Supervisor · born 1994
- Mr. Bin WuDeputy GM & Director · born 1987
- Mr. Zhongliang ZhangDeputy GM & Employee Director · born 1976
- Mr. Meng liang LiDeputy GM & Secretary of the Board · born 1987
- Ms. Fang PanDeputy General Manager · born 1973
- Mr. Dingan ZhangDeputy General Manager · born 1974